Mesoblast Ltd
MESO· Nasdaq
MESOMesoblast Ltd
Source filing unavailable
| Metric | Q3 2019 | Q3 2018 |
|---|---|---|
| Revenue | $1.25M | $1.07M |
| Net Income | -$24.97M | -$21.14M |
| EPS Diluted | -$0.05 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesoblast Ltd · CIK 1345099 · Engraved from SEC EDGAR
